Abstract
To demonstrate the feasibility and efficacy of six ambulatory high-dose sequential chemotherapy courses that include three intensified cycles supported by stem-cell infusion in high-risk and high-intermediate-risk untreated non-Hodgkin's lymphoma (NHL) patients. A pilot nonrandomized study included 20 untreated patients aged less than 60 years with aggressive histologically identified NHL and two or three adverse-prognosis criteria (International Index). Patients received an ambulatory regimen with high-dose chemotherapy supported by granulocyte colony-stimulating factor (G-CSF) and repeated peripheral-blood stem-cell (PBSC) infusion. The median age was 39 years (range, 20 to 59), with 13 men and seven women. Chemotherapy consisted of one cycle every 21 days for a total of six cycles. The first three cycles (A1, A2, and A3) consisted of cyclophosphamide (Cy) 3,000 mg/m2, doxorubicin (Doxo) 75 mg/m2, and vincristine 2 mg (plus corticosteroids). The last three cycles (B4, B5, and B6) consisted of the same drug combination plus etoposide 300 mg/m2 and cisplatin 100 mg/m2. For an expected duration of 18 weeks, the projected dose-intensity was 25 mg/m2/wk for Doxo and 1,000 mg/m2/wk for Cy. G-CSF 300 micrograms was administered from...Continue Reading
Citations
Feb 2, 2000·Bone Marrow Transplantation·R BouabdallahJ A Gastaut
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H TillyB Coiffier
Jan 6, 2001·Acta Oncologica·P O AnderssonT Ekman
May 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D StrotherA Gajjar
Feb 1, 2003·Transfusion·Nimrod SchwellaAbdulgabar Salama
Jun 25, 2003·Expert Review of Anticancer Therapy·Marcie Tomblyn, Jane N Winter
May 25, 2004·Leukemia & Lymphoma·Robert Marcus
Dec 7, 2005·Cancer·Nobert SchmitzUNKNOWN German High-Grade Non Hodgkin's Lymphoma Study Group (DSHNHL)
Mar 19, 2014·Leukemia & Lymphoma·Robert PytlíkUNKNOWN Czech Lymphoma Study Group
Apr 7, 1999·British Journal of Haematology·R A StahelH Honegger
Aug 28, 1998·Leukemia & Lymphoma·S OddouD Blaise
Apr 21, 2001·Bone Marrow Transplantation·A SalarUNKNOWN GEL/TAMO Spanish Cooperative Group
Dec 12, 2002·Bone Marrow Transplantation·F ViretP Viens
Oct 19, 2001·Bone Marrow Transplantation·K P PapadopoulosC S Hesdorffer
Jul 27, 2005·Bone Marrow Transplantation·K P PapadopoulosD G Savage
Apr 6, 2019·Blood Advances·Renato BassanAlessandro Rambaldi
Jun 25, 2002·Bone Marrow Transplantation·D GenreD Maraninchi
Feb 24, 2001·Leukemia·C DumontetB Coiffier
Apr 21, 2001·Bone Marrow Transplantation·J M VantelonV Ribrag
May 1, 2007·Transfusion·Kamran MovassaghiNimord Schwella
Feb 11, 2004·Cancer·Régis T CostelloJean-Albert Gastaut
Jun 14, 2006·Bone Marrow Transplantation·D CosoR Bouabdallah
Oct 3, 1999·British Journal of Cancer·P ViensP Pouillart
Jan 21, 2003·Leukemia & Lymphoma·Tetsuo YamazakiTakashi Horie
Apr 17, 2004·Internal Medicine Journal·N HorvathL B To
Sep 10, 2003·AIDS·Jérôme ReyRégis T Costello